---
title: 'Clinical Sales Specialist-Upper Midwest at Kiniksa Pharmaceuticals'
canonical: 'https://feeny.ai/job/clinical-sales-specialist-upper-midwest-kiniksa-pharmaceuticals-minneapolis-n81tj6c0s5dr'
type: 'job'
last_seen: '2026-09-14'
---

# Clinical Sales Specialist-Upper Midwest at Kiniksa Pharmaceuticals

- **Company:** Kiniksa Pharmaceuticals
- **Location:** Minneapolis, MN
- **Compensation:** $180k–$200k
- **Posted:** 2026-07-20
- **Last confirmed live:** 2026-09-14
- **Apply:** https://job-boards.greenhouse.io/kiniksapharmaceuticals/jobs/4324788009

## Job description

Kiniksa Pharmaceuticals is a commercial‑stage biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. With deep expertise in immunology and inflammation, Kiniksa is advancing a growing portfolio of approved and investigational medicines, anchored by its lead product, ARCALYST®, the first and only FDA‑approved therapy for recurrent pericarditis. Grounded in rigorous science and bold innovation, the company fosters a highly collaborative, patient‑first culture led by accomplished life sciences leaders. At Kiniksa, talented individuals are trusted and empowered to make a real impact—shaping the future of medicine while improving the lives of patients who need it most.

Reporting to the Regional Sales Director, the Clinical Sales Specialist (CSS) has the opportunity to contribute to the unique and exciting launch of rilonacept in recurrent pericarditis by educating healthcare providers and staff on recurrent pericarditis, drug efficacy and safety, treatment and administration, and patient services. The CSS is responsible for customer account targeting and planning across the assigned territory to maximize the customer and patient experience and deliver on business opportunities for Kiniksa.

Territory: ND, SD, most of Minnesota and NW corner of Iowa

Responsibilities (including, but not limited to):

- Develop and execute a strategic territory plan aligned with Kiniksa’s commercial objectives including prioritized territory and account management, business planning and analysis, and resource allocation
- Achieve the commercial goals set for launch
- Always act in a compliant manor with integrity aligned with Kiniksa’s values
- Educate targeted institutional decision makers, cardiologists and rheumatologists on the features, advantages and benefits of rilonacept
- Serve as the primary Kiniksa external representative for key HCP stakeholders , establishing oneself as a reliable, trusted resource for company and product information, appropriate use and dosing
- Drive cross-functional efficiencies and synergy with Kiniksa’s medical and payer field teams
- Identify and build advocacy with influential and respected recurrent pericarditis Thought Leaders
- Maintain updated customer and account profiles including institutional formularies and pathways and payer policies
- Provide a comprehensive overview on Kiniksa’s best-in class Patient Services and support program
- Facilitate collaborative opportunities aligned with Kiniksa’s mission, strategy and objectives through multiple venues, (virtual and in-person where applicable) one-on-one interactions, small group discussions, peer-to-peer programs and presentations with external key stakeholders
- Continuously build and maintain technical and clinical expertise across therapeutic areas and customer needs & expectations (territory market landscape, competitors, market segments/dynamics, disease state) to enable deep scientific discourse externally
- Maintain up-to-date knowledge on customer and healthcare trends within the cardiology space
- Promote a positive organization and brand image as Kiniksa enters the marketplace
- Attend appropriate scientific meetings
- Leverage clinical expertise to educate nurses on the administration of rilonacept
- Comply with applicable laws, internal and external guidelines, policies and procedures that govern Kiniksa activities
- Maintain expenses within assigned budget parameters
- Document field activities accurately and in a timely fashion

Qualifications and Experience:

- Requires a Bachelor's Degree with 5+ years of biopharmaceutical sales experience; specialty therapeutic experience. Cardiology experience is a plus
- Experience selling and demonstrating reconstitution and injection process is a must
- Candidates must demonstrate a track record of success
- Successfully demonstrated strategic account management experience
- Strong knowledge of the evolving patient and provider landscape
- Demonstrated working knowledge of compliant and ethical business practices
- Must exhibit a strong background in collaborating with internal and external stakeholders
- Must exhibit characteristics that exemplify drive, passion and focus that will translate into significant contributions towards building a global generational company focused on Kiniksa’s patients and customers
- Must demonstrate the ability to effectively & efficiently manage multiple workstreams
- Experience developing and executing a territory strategy with new drug launches preferred
- Must be willing to travel up to 75% of the time (primarily in the assigned territory) and hold a valid driver’s license

Compensation decisions are based on objective criteria including role responsibilities, experience/qualifications, internal equity, geographic location, and external market benchmarks. In addition to base pay, this role includes a Sales Incentive plan.

Sales pay range $180,000—$200,000 USD

Kiniksa is an Equal Opportunity employer and will consider you without regard to your race, color, religion, sex, sexual orientation, gender identity, transgender status, age, genetics, national origin, protected veteran status, or disability status, or any other legally protected category. We will ensure that individuals with disabilities are provided reasonable accommodation to participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment. Please contact us to request accommodation.

Kiniksa does not accept unsolicited resumes from staffing agencies or search firms. Any resumes submitted without a signed agreement will be considered property of Kiniksa, and no fees will be paid.

## About Kiniksa Pharmaceuticals

## Company Overview
- **One-liner**: Kiniksa Pharmaceuticals is a global biopharmaceutical company focused on discovering, developing, and commercializing novel, transformative therapies for patients with significant unmet medical needs, with a primary focus on cardiovascular diseases and immune modulation.
- **Entity Type**: Public (NASDAQ: KNSA)
- **Headquarters**: Lexington, Massachusetts, USA (with additional offices in La Jolla, CA; Zug, Switzerland; and London, UK)
- **Founded**: 2015
- **Founders**: Sanj K. Patel (CEO & Chairman)

## Core Business
- **Primary industry/industries**: Biopharmaceuticals, Biotechnology
- **Target customers**: Patients, healthcare providers, and payers (B2B/B2C model in specialty pharma)
- **Mission or purpose statement**: Dedicated to placing patients first and driving innovation in novel, life-changing therapies to address unmet medical need. The company operates under the belief that "every second makes a difference for patients living with debilitating diseases."

## Products & Services
- **ARCALYST® (rilonacept)**: An FDA-approved treatment for recurrent pericarditis — the first and only FDA-approved therapy for this indication. It is an interleukin-1 alpha and beta cytokine trap.
- **Mavrilimumab**: A clinical-stage anti-GM-CSF receptor alpha monoclonal antibody. A Phase 2 trial in non-mechanically ventilated severe COVID-19 patients yielded positive results. Kiniksa and Huadong Medicine have a collaboration to develop and commercialize it in the Asia Pacific region (excluding Japan).
- **Vixarelimab**: A clinical-stage asset acquired via a global license agreement with Roche and Genentech. It has received FDA Breakthrough Therapy designation for pruritus associated with prurigo nodularis.
- **KPL-404**: A clinical-stage asset for which Kiniksa has initiated a first-in-human study with an antigen challenge (TDAR).

## Market Standing
- **Valuation/Market Cap**: Approximately $1.7 billion (as of mid-2026)
- **Key Metric**: Annual Revenue of $677.6 million (as of mid-2026); Total Funding raised ~$80M in Series A and $170.7M in gross IPO proceeds (2018)
- **Notable Investors/Partners**: Huadong Medicine (Asia Pacific collaboration), Roche, Genentech
- **Growth Signals**: FDA approvals and breakthrough designations, expanding global footprint (UK, Switzerland, Netherlands offices), headcount of 310 employees and growing, active job postings (36 as of mid-2026)

## Competitive Advantages
- **Approved Commercial Product**: ARCALYST® is the first and only FDA-approved therapy for recurrent pericarditis, creating a strong market foothold and revenue stream.
- **Strong Pipeline**: Combination of FDA-approved therapy and clinical-stage assets with strong biologic rationale and validated pathways.
- **Strategic Collaborations**: Partnerships with Roche/Genentech and Huadong Medicine provide access to global markets and cutting-edge science.
- **Leadership**: Led by a team of distinguished life sciences leaders with over 30 years of combined industry experience.

## Strategic Focus
- **Current priorities**: Commercializing ARCALYST® and expanding its indications; advancing the pipeline of clinical-stage assets (mavrilimumab, vixarelimab, KPL-404); expanding global presence (especially in Asia Pacific and Europe); pursuing further strategic acquisitions and collaborations.
- **Patient-centric innovation**: Focus on immune modulation targeting unmet needs and underserved conditions.

## Why Work Here
- **Culture**: Fosters a culture of passion, innovation, and rapid execution. Employees are described as "highly skilled, driven people advancing their careers—and making a difference in patients' lives."
- **Commitment to employees**: Kiniksa is intentional about cultivating a highly skilled and passionate team determined to deliver on its promise to patients.
- **Work environment**: Global company with offices in the US (Lexington, MA; La Jolla, CA), Switzerland (Zug), and the UK (London). The company offers a collaborative, science-driven environment.
- **Diversity, Equity, and Inclusion**: Committed to creating a culture of equality that celebrates diversity and fosters innovation; an Equal Opportunity Employer.
- **Perks & Benefits (US)**:
    - **Healthcare & Well-being**: Robust PPO medical insurance (Blue Cross Blue Shield) with HRA to cover deductible; dental (including orthodontia); vision; flexible spending accounts; fertility benefits and parental leave (up to 10 weeks at 100% pay, plus 6-8 weeks disability for birth parents); behavioral health support via EAP; and mental health programs.
    - **Financial & Protection**: 401k with traditional and Roth options through Fidelity, with immediate company match; Employee Stock Purchase Plan (15% discount); employer-paid life and AD&D insurance; short- and long-term disability coverage; voluntary additional life insurance.
    - **Work-Life Balance**: Paid sick and vacation time; company-paid holidays; company-sponsored events and volunteer opportunities.
    - **Other**: Subsidized lunches; employee referral program; starting coverage on the first day of employment.

## Sources
1. [Kiniksa Pharmaceuticals - About Us](https://www.kiniksa.com/about)
2. [Kiniksa Pharmaceuticals - Join Us](https://www.kiniksa.com/join-us)
3. [Kiniksa Pharmaceuticals - Leadership](https://www.kiniksa.com/leadership)
4. [Kiniksa Pharmaceuticals - LinkedIn Company Page](https://www.linkedin.com/company/kiniksa-pharmaceuticals)
5. [Kiniksa Pharmaceuticals - Main Site](https://www.kiniksa.com/)

## Other roles at Kiniksa Pharmaceuticals

- [Specialist, Logistics and Customs Compliance](https://feeny.ai/job/specialist-logistics-and-customs-compliance-kiniksa-pharmaceuticals-lexington-7dy3npqatgvb) — Lexington, MA
- [IT Sr. Manager, Salesforce Solutions Architect – Commercial Applications](https://feeny.ai/job/it-sr-manager-salesforce-solutions-architect-commercial-applications-kiniksa-xfm84kq6f28c) — Lexington, MA
- [Desktop Support Engineer](https://feeny.ai/job/desktop-support-engineer-kiniksa-pharmaceuticals-lexington-hq1qa926j23w) — Lexington, MA
- [Associate Director, Patient Services Operations and Marketing](https://feeny.ai/job/associate-director-patient-services-operations-and-marketing-kiniksa-hk4zex4ryn89) — Lexington, MA
- [Assoc. Director, Patient Access Lead](https://feeny.ai/job/assoc-director-patient-access-lead-kiniksa-pharmaceuticals-lexington-5rh0a2tpgs8v) — Lexington, MA
- [Associate Director/Director,  Pre-Clinical Program & Alliance Management](https://feeny.ai/job/associate-director-director-pre-clinical-program-alliance-management-kiniksa-tmgjgxr6c836) — Lexington, MA
- [Sr. Sales Director - Central](https://feeny.ai/job/sr-sales-director-central-kiniksa-pharmaceuticals-1vbk1v0d66st)
- [Clinical Sales Specialist- Central](https://feeny.ai/job/clinical-sales-specialist-central-kiniksa-pharmaceuticals-a5r1bzmn3zsc)
- [Clinical Sales Specialist- West](https://feeny.ai/job/clinical-sales-specialist-west-kiniksa-pharmaceuticals-fzg6x0jg6wg5)
- [Clinical Sales Specialist- East](https://feeny.ai/job/clinical-sales-specialist-east-kiniksa-pharmaceuticals-yd26xq039jaw)